Since 1983, PROGEN has been an established manufacturer and supplier of premium antibodies, in vitro diagnostics, and reagents for the global life science research community. The company’s portfolio attracts and serves a well-diversified clientele in research institutes and universities, pharmaceutical and biotech companies as well as private and clinical laboratories. While PROGEN ’s antibodies are among the most published antibodies in biomedical and cell biology literature, its ELISA kits aim at niche markets in microbiology, infectious diseases, and immunology. Building on its extensive core-competency and experience in immunochemistry, the company has expanded its product and service portfolio in recent years to include recombinant antibody engineering, antibody phage display technology, density gradient media, and AAV (adeno-associated virus) test kits for gene therapy research.


Research & Development

PROGEN is a specialist for premium immunochemicals since 1983. The company develops and manufactures test kits and reagents marketed as PROGEN products and is expanding its product portfolio on a continuous basis. The German Stifterverband has recognized PROGEN's research activities with the "Innovative through Research" award (2018).

Progen, Germany